These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6823092)

  • 1. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.
    Kisilevsky R; Boudreau L; Foster D
    Lab Invest; 1983 Jan; 48(1):60-7. PubMed ID: 6823092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy.
    Kisilevsky R; Boudreau L
    Lab Invest; 1983 Jan; 48(1):53-9. PubMed ID: 6823091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition.
    Kisilevsky R; Benson MD; Axelrad MA; Boudreau L
    Lab Invest; 1979 Sep; 41(3):206-10. PubMed ID: 470340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
    Cui D; Hoshii Y; Kawano H; Sugiyama S; Gondo T; Liu Y; Ishihara T
    Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
    Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
    J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
    Benson MD; Kleiner E
    J Immunol; 1980 Feb; 124(2):495-9. PubMed ID: 6985931
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
    Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
    Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
    Kawahara E; Shiroo M; Nakanishi I; Migita S
    Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin: its potential significance in murine AA amyloidogenesis.
    Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
    J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
    Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
    Snow AD; Kisilevsky R
    Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T; Husby G
    J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.
    Kluve-Beckerman B; Hardwick J; Du L; Benson MD; Monia BP; Watt A; Crooke RM; Mullick A
    Amyloid; 2011 Sep; 18(3):136-46. PubMed ID: 21830877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response.
    Brandwein SR; Sipe JD; Tatsuta E; Skinner M; Cohen AS
    J Rheumatol; 1984 Oct; 11(5):597-601. PubMed ID: 6334740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection.
    Miura K; Takahashi Y; Shirasawa H
    Lab Invest; 1985 Oct; 53(4):453-63. PubMed ID: 3900582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies.
    Arai K; Miura K; Baba S; Shirasawa H
    J Pathol; 1994 Jun; 173(2):127-34. PubMed ID: 8089807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.